Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 46 | 2024 | 3204 | 5.540 |
Why?
|
Spirometry | 19 | 2024 | 929 | 2.410 |
Why?
|
Forced Expiratory Volume | 16 | 2024 | 1814 | 1.970 |
Why?
|
Vital Capacity | 12 | 2024 | 971 | 1.650 |
Why?
|
Veterans | 9 | 2024 | 2649 | 1.180 |
Why?
|
Respiratory Function Tests | 6 | 2024 | 1682 | 1.090 |
Why?
|
Actigraphy | 4 | 2023 | 520 | 1.030 |
Why?
|
Pulmonary Emphysema | 5 | 2020 | 684 | 1.030 |
Why?
|
Lung | 17 | 2024 | 10002 | 1.010 |
Why?
|
DNA Methylation | 6 | 2021 | 4399 | 0.990 |
Why?
|
Exercise Tolerance | 6 | 2022 | 836 | 0.970 |
Why?
|
Total Lung Capacity | 3 | 2020 | 149 | 0.800 |
Why?
|
Smoking | 16 | 2023 | 9053 | 0.790 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2022 | 189 | 0.770 |
Why?
|
Exercise | 6 | 2023 | 5890 | 0.740 |
Why?
|
Thorax | 1 | 2023 | 555 | 0.700 |
Why?
|
Epigenesis, Genetic | 4 | 2021 | 3801 | 0.520 |
Why?
|
Absorptiometry, Photon | 1 | 2022 | 1738 | 0.510 |
Why?
|
Klinefelter Syndrome | 1 | 2015 | 47 | 0.490 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.430 |
Why?
|
Blood Cells | 1 | 2015 | 305 | 0.430 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 17904 | 0.430 |
Why?
|
Mouth Mucosa | 1 | 2015 | 432 | 0.410 |
Why?
|
Walking | 1 | 2020 | 1198 | 0.410 |
Why?
|
Adiposity | 1 | 2022 | 1879 | 0.390 |
Why?
|
Lung Diseases | 1 | 2021 | 1909 | 0.380 |
Why?
|
Dyspnea | 5 | 2024 | 1347 | 0.370 |
Why?
|
Genome-Wide Association Study | 10 | 2024 | 12690 | 0.360 |
Why?
|
Bronchitis, Chronic | 3 | 2024 | 82 | 0.350 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 918 | 0.350 |
Why?
|
Middle Aged | 39 | 2024 | 220920 | 0.320 |
Why?
|
Aged | 31 | 2023 | 169310 | 0.300 |
Why?
|
Williams Syndrome | 1 | 2010 | 194 | 0.290 |
Why?
|
Genome, Human | 3 | 2015 | 4425 | 0.280 |
Why?
|
CpG Islands | 4 | 2015 | 1230 | 0.270 |
Why?
|
Self Report | 1 | 2018 | 3725 | 0.270 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3701 | 0.270 |
Why?
|
Male | 40 | 2024 | 360842 | 0.260 |
Why?
|
Humans | 61 | 2024 | 761572 | 0.250 |
Why?
|
Female | 41 | 2024 | 392686 | 0.250 |
Why?
|
Carrier Proteins | 1 | 2017 | 4937 | 0.230 |
Why?
|
Glucocorticoids | 1 | 2012 | 2161 | 0.210 |
Why?
|
Aged, 80 and over | 12 | 2021 | 58986 | 0.210 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 2 | 2021 | 111 | 0.210 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26127 | 0.200 |
Why?
|
Aging | 1 | 2021 | 8711 | 0.200 |
Why?
|
United States Department of Veterans Affairs | 2 | 2024 | 928 | 0.200 |
Why?
|
Sickle Cell Trait | 1 | 2022 | 85 | 0.190 |
Why?
|
Genomics | 1 | 2017 | 5821 | 0.180 |
Why?
|
Japan | 2 | 2022 | 1378 | 0.180 |
Why?
|
Smoking Cessation | 1 | 2012 | 2057 | 0.170 |
Why?
|
Mucins | 1 | 2023 | 568 | 0.170 |
Why?
|
Bronchodilator Agents | 2 | 2021 | 512 | 0.170 |
Why?
|
Disease Progression | 6 | 2021 | 13510 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2017 | 15936 | 0.160 |
Why?
|
Phenotype | 7 | 2023 | 16592 | 0.160 |
Why?
|
Quality of Life | 7 | 2023 | 13367 | 0.160 |
Why?
|
Body Composition | 2 | 2022 | 2426 | 0.150 |
Why?
|
Electric Impedance | 1 | 2022 | 757 | 0.140 |
Why?
|
Metabolomics | 2 | 2017 | 1659 | 0.140 |
Why?
|
Boston | 2 | 2022 | 9326 | 0.140 |
Why?
|
Mannose-Binding Lectin | 1 | 2018 | 145 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 515 | 0.140 |
Why?
|
Risk | 2 | 2020 | 9610 | 0.130 |
Why?
|
Internet | 2 | 2020 | 3093 | 0.130 |
Why?
|
Body Mass Index | 2 | 2011 | 12954 | 0.130 |
Why?
|
Cohort Studies | 8 | 2021 | 41493 | 0.130 |
Why?
|
Proteins | 1 | 2010 | 6032 | 0.130 |
Why?
|
Metabolism, Inborn Errors | 1 | 2018 | 284 | 0.130 |
Why?
|
Self Efficacy | 1 | 2020 | 638 | 0.130 |
Why?
|
Genotype | 5 | 2022 | 12990 | 0.120 |
Why?
|
Occupational Exposure | 2 | 2024 | 1813 | 0.120 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 25 | 0.120 |
Why?
|
United States | 7 | 2024 | 72335 | 0.120 |
Why?
|
Risk Factors | 13 | 2023 | 74213 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2019 | 22176 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.110 |
Why?
|
Respiratory System | 1 | 2016 | 563 | 0.100 |
Why?
|
Goals | 1 | 2018 | 711 | 0.100 |
Why?
|
Pulmonary Artery | 1 | 2021 | 1927 | 0.100 |
Why?
|
Ankyrins | 1 | 2012 | 123 | 0.100 |
Why?
|
Iron Regulatory Protein 2 | 1 | 2012 | 42 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 164 | 0.100 |
Why?
|
Receptors, Thrombin | 1 | 2012 | 130 | 0.100 |
Why?
|
Seasons | 1 | 2017 | 1520 | 0.090 |
Why?
|
Respiration | 1 | 2017 | 1657 | 0.090 |
Why?
|
Checklist | 1 | 2018 | 827 | 0.090 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15266 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 350 | 0.090 |
Why?
|
Receptors, Peptide | 1 | 2012 | 279 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2018 | 14607 | 0.090 |
Why?
|
Adult | 12 | 2024 | 221203 | 0.090 |
Why?
|
Heterozygote | 1 | 2017 | 2787 | 0.090 |
Why?
|
Exercise Test | 1 | 2018 | 2127 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39107 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1924 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20571 | 0.080 |
Why?
|
Norway | 1 | 2010 | 499 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 310 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2421 | 0.080 |
Why?
|
alpha 1-Antitrypsin | 1 | 2009 | 167 | 0.080 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 112 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 2012 | 495 | 0.080 |
Why?
|
Elastin | 1 | 2010 | 298 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2015 | 705 | 0.080 |
Why?
|
Prevalence | 2 | 2023 | 15732 | 0.080 |
Why?
|
Administration, Inhalation | 1 | 2021 | 1157 | 0.070 |
Why?
|
Motivation | 1 | 2017 | 2006 | 0.070 |
Why?
|
Genetic Loci | 1 | 2017 | 2632 | 0.070 |
Why?
|
Social Support | 1 | 2017 | 2171 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2707 | 0.070 |
Why?
|
Pain | 1 | 2021 | 5073 | 0.070 |
Why?
|
Antigens, CD | 1 | 2016 | 4001 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8002 | 0.060 |
Why?
|
Osteoporosis | 1 | 2015 | 1606 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12148 | 0.060 |
Why?
|
Chromosome Deletion | 1 | 2010 | 1386 | 0.060 |
Why?
|
Poland | 2 | 2017 | 198 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4415 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1250 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4811 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2009 | 2341 | 0.060 |
Why?
|
Asthma | 3 | 2017 | 6234 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5336 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20099 | 0.060 |
Why?
|
Gases | 1 | 2024 | 204 | 0.050 |
Why?
|
DNA | 1 | 2016 | 7213 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2021 | 80646 | 0.050 |
Why?
|
Depression | 2 | 2023 | 8124 | 0.050 |
Why?
|
Smoke | 1 | 2024 | 235 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
Bone Density | 1 | 2015 | 3551 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1881 | 0.050 |
Why?
|
Family | 1 | 2012 | 3194 | 0.050 |
Why?
|
Mucus | 1 | 2023 | 341 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10553 | 0.050 |
Why?
|
Dust | 1 | 2024 | 487 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 14032 | 0.050 |
Why?
|
Logistic Models | 2 | 2017 | 13255 | 0.050 |
Why?
|
Sputum | 1 | 2023 | 506 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6312 | 0.050 |
Why?
|
Genetic Variation | 2 | 2021 | 6567 | 0.050 |
Why?
|
Veterans Health | 1 | 2022 | 215 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4618 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36192 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29629 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 3415 | 0.040 |
Why?
|
Thymidine Phosphorylase | 1 | 1998 | 14 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39970 | 0.040 |
Why?
|
HT29 Cells | 1 | 1998 | 193 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18253 | 0.040 |
Why?
|
Mice | 2 | 2017 | 81533 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10773 | 0.030 |
Why?
|
Animals | 3 | 2017 | 168467 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15843 | 0.030 |
Why?
|
Hemoglobins | 1 | 2022 | 1526 | 0.030 |
Why?
|
Sarcoglycans | 1 | 2015 | 57 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15501 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 590 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7858 | 0.030 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 231 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 57 | 0.030 |
Why?
|
Breath Tests | 1 | 2016 | 299 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 358 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 54426 | 0.030 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2015 | 144 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1597 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2330 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1512 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4243 | 0.020 |
Why?
|
North America | 1 | 2015 | 1276 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2012 | 287 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 277 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3416 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5872 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 832 | 0.020 |
Why?
|
Cadherins | 1 | 2015 | 903 | 0.020 |
Why?
|
Haplotypes | 1 | 2016 | 2713 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2684 | 0.020 |
Why?
|
Cough | 1 | 2013 | 594 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 64684 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2024 | 4486 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3422 | 0.020 |
Why?
|
Morbidity | 1 | 2013 | 1750 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1902 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3250 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21355 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1998 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7047 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4615 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4948 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7967 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6864 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3113 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9646 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2735 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10212 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8466 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 59255 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10721 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10508 | 0.010 |
Why?
|
Adolescent | 1 | 2010 | 88324 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1998 | 189 | 0.010 |
Why?
|
Dactinomycin | 1 | 1998 | 304 | 0.010 |
Why?
|
Interferon-alpha | 1 | 1998 | 921 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 1171 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1756 | 0.010 |
Why?
|
Kinetics | 1 | 1998 | 6374 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6534 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12441 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17635 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 12794 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1998 | 8552 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1998 | 13642 | 0.000 |
Why?
|
Concepts
(215)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(55)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_